Symbols / RDY Stock $13.66 +6.35% Dr. Reddy's Laboratories Limited
RDY (Stock) Chart
About
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Stock Fundamentals
Scroll to Statements| Market Cap | 11.40B | Enterprise Value | -776.82M | Income | 56.59B | Sales | 345.83B | Book/sh | 0.81 | Cash/sh | 99.20 |
| Dividend Yield | 71.00% | Payout | 11.82% | Employees | 27811 | IPO | — | P/E | 18.71 | Forward P/E | 24.67 |
| PEG | 3.54 | P/S | 0.03 | P/B | 16.93 | P/C | — | EV/EBITDA | -0.01 | EV/Sales | -0.00 |
| Quick Ratio | 1.18 | Current Ratio | 1.88 | Debt/Eq | 18.03 | LT Debt/Eq | — | EPS (ttm) | 0.73 | EPS next Y | 0.55 |
| EPS Growth | -14.30% | Revenue Growth | 4.40% | Earnings | 2026-05-12 | ROA | 7.96% | ROE | 16.10% | ROIC | — |
| Gross Margin | 55.18% | Oper. Margin | 16.42% | Profit Margin | 16.36% | Shs Outstand | 832.59M | Shs Float | 599.15M | Short Float | 3.42% |
| Short Ratio | 6.63 | Short Interest | — | 52W High | 16.17 | 52W Low | 12.77 | Beta | 0.30 | Avg Volume | 2.15M |
| Volume | 2.96M | Target Price | $14.16 | Recom | Hold | Prev Close | $12.84 | Price | $13.65 | Change | 6.35% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-06-05 | up | HSBC | Hold → Buy | $17 |
| 2024-11-06 | main | Barclays | Overweight → Overweight | $17 |
| 2024-07-30 | main | Barclays | Overweight → Overweight | $87 |
| 2024-05-08 | main | Barclays | Overweight → Overweight | $81 |
| 2024-01-29 | main | Barclays | Overweight → Overweight | $80 |
| 2023-06-01 | main | Barclays | Overweight → Overweight | $70 |
| 2022-10-31 | main | Barclays | — → Overweight | $67 |
| 2022-10-25 | main | Barclays | — → Overweight | $66 |
| 2022-09-12 | main | Barclays | — → Overweight | $69 |
| 2022-07-25 | main | Barclays | — → Overweight | $68 |
| 2022-05-24 | main | Barclays | — → Overweight | $70 |
| 2021-11-01 | main | Barclays | — → Overweight | $80 |
| 2021-02-02 | up | Barclays | Equal-Weight → Overweight | $70 |
| 2020-01-28 | down | CLSA | Buy → Outperform | — |
| 2020-01-09 | up | Citigroup | Sell → Buy | — |
| 2019-11-04 | down | B of A Securities | Buy → Neutral | — |
| 2019-09-04 | up | Credit Suisse | Underperform → Outperform | — |
| 2019-06-11 | init | Barclays | — → Equal-Weight | $39 |
| 2019-05-20 | down | Morgan Stanley | Overweight → Equal-Weight | — |
| 2017-11-01 | main | Jefferies | — → Underperform | $31 |
News
RSS: Latest RDY news- Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What Happened - MarketBeat hu, 23 Apr 2026 15
- (RDY) Movement as an Input in Quant Signal Sets - Stock Traders Daily hu, 23 Apr 2026 07
- Why Dr Reddy’s Stock Is Suddenly Sliding - TipRanks hu, 23 Apr 2026 09
- Is Dr. (RDY) stock still attractive | Q1 2026: EPS Beats Forecasts - Open Stock Signal Network - Xã Vĩnh Công hu, 23 Apr 2026 10
- RDY Stock Price, Quote & Chart | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill Fri, 17 Apr 2026 07
- Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Insights into a Leading Indian Pharmaceutical Player with a 7.58% Potential Upside - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Dr. Reddy’s (NYSE: RDY) board to consider FY 2025-26 final dividend - Stock Titan hu, 16 Apr 2026 13
- Dr. Reddy's Laboratories (NYSE:RDY) Sets New 1-Year Low - Time to Sell? - MarketBeat ue, 21 Apr 2026 18
- Peter Lynch's GARP Strategy Identifies DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) as a Candidate - ChartMill Mon, 20 Apr 2026 10
- Is Dr. (RDY) stock still attractive | Q1 2026: EPS Beats Forecasts - Popular Market Picks - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 21
- Dr Reddy’s (NYSE: RDY) Europe head reports 8,450 ADR-backed shares - Stock Titan Wed, 01 Apr 2026 07
- Dr. Reddy's Laboratories-ADR (NYSE:RDY) Passes Peter Lynch's GARP Investment Filter - ChartMill Sat, 10 Jan 2026 08
- Dr Reddys (RDY) quality head reports direct holding of 35,600 shares - Stock Titan Fri, 10 Apr 2026 07
- Russian tax authority cuts penalty for Dr. Reddy’s (NYSE: RDY) - Stock Titan Wed, 15 Apr 2026 10
- Dr. Reddy's Laboratories (NYSE:RDY) Passes Key Peter Lynch GARP Investment Test - ChartMill ue, 03 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
325,535.00
+16.61%
|
279,164.00
+13.54%
|
245,879.00
+14.69%
|
214,391.00
|
| Operating Revenue |
|
325,535.00
+16.61%
|
279,164.00
+13.54%
|
245,879.00
+14.69%
|
214,391.00
|
| Cost Of Revenue |
|
135,107.00
+16.92%
|
115,557.00
+8.47%
|
106,536.00
+5.95%
|
100,551.00
|
| Reconciled Cost Of Revenue |
|
135,107.00
+16.92%
|
115,557.00
+8.47%
|
106,536.00
+5.95%
|
100,551.00
|
| Gross Profit |
|
190,428.00
+16.39%
|
163,607.00
+17.41%
|
139,343.00
+22.40%
|
113,840.00
|
| Operating Expense |
|
118,414.00
+20.46%
|
98,299.00
+22.43%
|
80,289.00
+3.04%
|
77,921.00
|
| Research And Development |
|
27,380.00
+19.70%
|
22,873.00
+18.02%
|
19,381.00
+10.86%
|
17,482.00
|
| Selling General And Administration |
|
93,870.00
+21.59%
|
77,201.00
+13.49%
|
68,026.00
+9.58%
|
62,081.00
|
| Other Operating Expenses |
|
-2,836.00
-59.77%
|
-1,775.00
+75.06%
|
-7,118.00
-333.50%
|
-1,642.00
|
| Total Expenses |
|
253,521.00
+18.55%
|
213,856.00
+14.47%
|
186,825.00
+4.68%
|
178,472.00
|
| Operating Income |
|
72,014.00
+10.27%
|
65,308.00
+10.59%
|
59,054.00
+64.41%
|
35,919.00
|
| Total Operating Income As Reported |
|
71,843.00
+6.07%
|
67,729.00
+18.52%
|
57,144.00
+93.87%
|
29,476.00
|
| EBITDA |
|
96,671.00
+9.33%
|
88,422.00
+18.80%
|
74,431.00
+65.11%
|
45,080.00
|
| Normalized EBITDA |
|
91,966.00
+11.37%
|
82,574.00
+12.74%
|
73,240.00
+48.23%
|
49,411.00
|
| Reconciled Depreciation |
|
17,058.00
+14.94%
|
14,841.00
+17.45%
|
12,636.00
+6.87%
|
11,824.00
|
| EBIT |
|
79,613.00
+8.20%
|
73,581.00
+19.07%
|
61,795.00
+85.82%
|
33,256.00
|
| Total Unusual Items |
|
4,705.00
-19.55%
|
5,848.00
+391.02%
|
1,191.00
+127.50%
|
-4,331.00
|
| Total Unusual Items Excluding Goodwill |
|
4,705.00
-19.55%
|
5,848.00
+391.02%
|
1,191.00
+127.50%
|
-4,331.00
|
| Special Income Charges |
|
-171.00
-107.06%
|
2,421.00
+226.75%
|
-1,910.00
+70.36%
|
-6,443.00
|
| Other Special Charges |
|
—
|
-1,524.00
|
—
|
—
|
| Impairment Of Capital Assets |
|
1,693.00
+56333.33%
|
3.00
-99.57%
|
699.00
-90.76%
|
7,562.00
|
| Write Off |
|
—
|
3.00
-99.57%
|
699.00
-90.76%
|
7,562.00
|
| Net Income |
|
56,544.00
+1.54%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Pretax Income |
|
76,784.00
+6.84%
|
71,870.00
+19.06%
|
60,367.00
+86.91%
|
32,298.00
|
| Net Non Operating Interest Income Expense |
|
-152.00
-126.81%
|
567.00
+328.63%
|
-248.00
-3642.86%
|
7.00
|
| Interest Expense Non Operating |
|
2,829.00
+65.34%
|
1,711.00
+19.82%
|
1,428.00
+49.06%
|
958.00
|
| Net Interest Income |
|
-152.00
-126.81%
|
567.00
+328.63%
|
-248.00
-3642.86%
|
7.00
|
| Interest Expense |
|
2,829.00
+65.34%
|
1,711.00
+19.82%
|
1,428.00
+49.06%
|
958.00
|
| Interest Income Non Operating |
|
2,677.00
+17.52%
|
2,278.00
+93.05%
|
1,180.00
+22.28%
|
965.00
|
| Interest Income |
|
2,677.00
+17.52%
|
2,278.00
+93.05%
|
1,180.00
+22.28%
|
965.00
|
| Other Income Expense |
|
4,922.00
-17.90%
|
5,995.00
+284.05%
|
1,561.00
+143.03%
|
-3,628.00
|
| Gain On Sale Of Security |
|
4,876.00
+42.28%
|
3,427.00
+10.51%
|
3,101.00
+46.83%
|
2,112.00
|
| Tax Provision |
|
19,539.00
+20.72%
|
16,186.00
+5.79%
|
15,300.00
+75.26%
|
8,730.00
|
| Tax Rate For Calcs |
|
0.00
+8.70%
|
0.00
-8.00%
|
0.00
-7.41%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1,176.25
-12.55%
|
1,345.04
+351.73%
|
297.75
+125.46%
|
-1,169.37
|
| Net Income Including Noncontrolling Interests |
|
57,245.00
+2.80%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
56,544.00
+1.54%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Net Income From Continuing And Discontinued Operation |
|
56,544.00
+1.54%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Net Income Continuous Operations |
|
57,245.00
+2.80%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Minority Interests |
|
-701.00
|
0.00
|
0.00
|
—
|
| Normalized Income |
|
53,015.25
+3.58%
|
51,181.04
+15.86%
|
44,173.75
+65.26%
|
26,729.63
|
| Net Income Common Stockholders |
|
56,544.00
+1.54%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Diluted EPS |
|
67.79
+1.30%
|
66.92
+23.51%
|
54.18
+91.19%
|
28.34
|
| Basic EPS |
|
67.89
+1.26%
|
67.04
+23.48%
|
54.29
+91.07%
|
28.42
|
| Basic Average Shares |
|
832.98
+0.12%
|
831.98
+0.22%
|
830.17
+0.09%
|
829.39
|
| Diluted Average Shares |
|
834.21
+0.08%
|
833.54
+0.20%
|
831.91
+0.03%
|
831.67
|
| Diluted NI Availto Com Stockholders |
|
56,544.00
+1.54%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Earnings From Equity Interest |
|
217.00
+47.62%
|
147.00
-60.27%
|
370.00
-47.37%
|
703.00
|
| Gain On Sale Of PPE |
|
1,522.00
+69.11%
|
900.00
+174.32%
|
-1,211.00
-208.22%
|
1,119.00
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
492,989.00
+27.22%
|
387,518.00
+20.40%
|
321,854.00
+9.91%
|
292,827.00
|
| Current Assets |
|
250,112.00
+0.83%
|
248,049.00
+21.44%
|
204,253.00
+12.32%
|
181,856.00
|
| Cash Cash Equivalents And Short Term Investments |
|
57,908.00
-28.92%
|
81,470.00
+31.83%
|
61,797.00
+39.29%
|
44,365.00
|
| Cash And Cash Equivalents |
|
14,654.00
+106.19%
|
7,107.00
+22.98%
|
5,779.00
-61.09%
|
14,852.00
|
| Cash Equivalents |
|
2,511.00
-2.86%
|
2,585.00
-5.76%
|
2,743.00
+668.35%
|
357.00
|
| Cash Financial |
|
12,143.00
+168.53%
|
4,522.00
+48.95%
|
3,036.00
-79.05%
|
14,495.00
|
| Other Short Term Investments |
|
43,254.00
-41.83%
|
74,363.00
+32.75%
|
56,018.00
+89.81%
|
29,513.00
|
| Receivables |
|
109,792.00
+15.16%
|
95,338.00
+14.58%
|
83,203.00
+3.65%
|
80,270.00
|
| Accounts Receivable |
|
90,420.00
+12.61%
|
80,298.00
+10.78%
|
72,485.00
+8.57%
|
66,764.00
|
| Gross Accounts Receivable |
|
91,898.00
+12.41%
|
81,749.00
+10.86%
|
73,743.00
+8.51%
|
67,958.00
|
| Allowance For Doubtful Accounts Receivable |
|
-1,478.00
-1.86%
|
-1,451.00
-15.34%
|
-1,258.00
-5.36%
|
-1,194.00
|
| Other Receivables |
|
19,372.00
+28.80%
|
15,040.00
+40.32%
|
10,718.00
+13.17%
|
9,471.00
|
| Taxes Receivable |
|
—
|
—
|
2,687.00
-33.41%
|
4,035.00
|
| Inventory |
|
71,085.00
+11.85%
|
63,552.00
+30.58%
|
48,670.00
-4.35%
|
50,884.00
|
| Raw Materials |
|
26,165.00
+8.65%
|
24,081.00
+50.50%
|
16,001.00
-8.60%
|
17,507.00
|
| Work In Process |
|
16,525.00
+16.19%
|
14,222.00
+21.58%
|
11,698.00
-9.22%
|
12,886.00
|
| Finished Goods |
|
28,395.00
+12.46%
|
25,249.00
+20.40%
|
20,971.00
+2.34%
|
20,491.00
|
| Prepaid Assets |
|
6,768.00
+42.51%
|
4,749.00
+13.72%
|
4,176.00
+266.96%
|
1,138.00
|
| Assets Held For Sale Current |
|
—
|
—
|
—
|
0.00
|
| Hedging Assets Current |
|
557.00
+229.59%
|
169.00
-86.28%
|
1,232.00
-35.36%
|
1,906.00
|
| Other Current Assets |
|
4,002.00
+44.42%
|
2,771.00
-46.45%
|
5,175.00
+57.15%
|
3,293.00
|
| Total Non Current Assets |
|
242,877.00
+74.14%
|
139,469.00
+18.60%
|
117,601.00
+5.97%
|
110,971.00
|
| Net PPE |
|
97,761.00
+27.15%
|
76,886.00
+15.68%
|
66,462.00
+6.91%
|
62,169.00
|
| Gross PPE |
|
190,380.00
+11.90%
|
170,140.00
+11.74%
|
152,269.00
+7.24%
|
141,987.00
|
| Accumulated Depreciation |
|
-92,619.00
+0.68%
|
-93,254.00
-8.68%
|
-85,807.00
-7.50%
|
-79,818.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
4,243.00
-1.53%
|
4,309.00
-0.21%
|
4,318.00
+2.01%
|
4,233.00
|
| Buildings And Improvements |
|
34,653.00
+4.91%
|
33,032.00
+11.13%
|
29,724.00
+4.58%
|
28,422.00
|
| Machinery Furniture Equipment |
|
126,646.00
+7.02%
|
118,338.00
+9.30%
|
108,268.00
+12.85%
|
95,938.00
|
| Construction In Progress |
|
24,838.00
+71.77%
|
14,460.00
+45.24%
|
9,956.00
-25.67%
|
13,394.00
|
| Other Properties |
|
—
|
3.00
+0.00%
|
3.00
|
—
|
| Goodwill And Other Intangible Assets |
|
108,613.00
+163.60%
|
41,204.00
+17.41%
|
35,094.00
+10.83%
|
31,664.00
|
| Goodwill |
|
11,810.00
+177.69%
|
4,253.00
+0.19%
|
4,245.00
-3.92%
|
4,418.00
|
| Other Intangible Assets |
|
96,803.00
+161.98%
|
36,951.00
+19.78%
|
30,849.00
+13.22%
|
27,246.00
|
| Investments And Advances |
|
15,202.00
+189.29%
|
5,255.00
-2.00%
|
5,362.00
-32.86%
|
7,986.00
|
| Long Term Equity Investment |
|
4,811.00
+14.66%
|
4,196.00
-10.76%
|
4,702.00
+8.89%
|
4,318.00
|
| Non Current Accounts Receivable |
|
1,821.00
-51.02%
|
3,718.00
+38.37%
|
2,687.00
+4875.93%
|
54.00
|
| Non Current Deferred Assets |
|
18,508.00
+71.78%
|
10,774.00
+49.72%
|
7,196.00
-12.29%
|
8,204.00
|
| Non Current Deferred Taxes Assets |
|
18,508.00
+71.78%
|
10,774.00
+49.72%
|
7,196.00
-12.29%
|
8,204.00
|
| Non Current Prepaid Assets |
|
750.00
+0.40%
|
747.00
+11.83%
|
668.00
-0.30%
|
670.00
|
| Other Non Current Assets |
|
222.00
-74.92%
|
885.00
+570.45%
|
132.00
-41.07%
|
224.00
|
| Total Liabilities Net Minority Interest |
|
155,823.00
+45.67%
|
106,968.00
+17.72%
|
90,863.00
-11.18%
|
102,300.00
|
| Current Liabilities |
|
130,392.00
+35.77%
|
96,039.00
+11.87%
|
85,845.00
-8.69%
|
94,015.00
|
| Payables And Accrued Expenses |
|
75,984.00
+9.87%
|
69,157.00
+10.69%
|
62,477.00
+10.42%
|
56,579.00
|
| Payables |
|
50,849.00
+14.59%
|
44,374.00
+9.21%
|
40,633.00
+11.25%
|
36,524.00
|
| Accounts Payable |
|
20,053.00
-6.93%
|
21,547.00
+20.66%
|
17,857.00
+11.81%
|
15,971.00
|
| Other Payable |
|
27,768.00
+35.55%
|
20,485.00
-0.71%
|
20,632.00
+8.94%
|
18,938.00
|
| Current Accrued Expenses |
|
25,135.00
+1.42%
|
24,783.00
+13.45%
|
21,844.00
+8.92%
|
20,055.00
|
| Total Tax Payable |
|
3,028.00
+29.29%
|
2,342.00
+9.24%
|
2,144.00
+32.76%
|
1,615.00
|
| Current Debt And Capital Lease Obligation |
|
38,902.00
+177.28%
|
14,030.00
+15.06%
|
12,194.00
-56.60%
|
28,099.00
|
| Current Debt |
|
38,045.00
+199.03%
|
12,723.00
+13.70%
|
11,190.00
-58.68%
|
27,082.00
|
| Other Current Borrowings |
|
—
|
10,223.00
+169.03%
|
3,800.00
-57.16%
|
8,871.00
|
| Current Capital Lease Obligation |
|
857.00
-34.43%
|
1,307.00
+30.18%
|
1,004.00
-1.28%
|
1,017.00
|
| Current Deferred Liabilities |
|
1,983.00
+38.19%
|
1,435.00
-27.56%
|
1,981.00
-23.10%
|
2,576.00
|
| Current Deferred Revenue |
|
1,983.00
+38.19%
|
1,435.00
-27.56%
|
1,981.00
-23.10%
|
2,576.00
|
| Other Current Liabilities |
|
7,355.00
+21.89%
|
6,034.00
+61.38%
|
3,739.00
+49.38%
|
2,503.00
|
| Total Non Current Liabilities Net Minority Interest |
|
25,431.00
+132.69%
|
10,929.00
+117.80%
|
5,018.00
-39.43%
|
8,285.00
|
| Long Term Debt And Capital Lease Obligation |
|
7,864.00
+31.29%
|
5,990.00
+368.70%
|
1,278.00
-77.76%
|
5,746.00
|
| Long Term Debt |
|
3,800.00
+0.00%
|
3,800.00
|
—
|
3,800.00
|
| Long Term Capital Lease Obligation |
|
4,064.00
+85.57%
|
2,190.00
+71.36%
|
1,278.00
-34.33%
|
1,946.00
|
| Long Term Provisions |
|
156.00
+155.74%
|
61.00
+3.39%
|
59.00
+3.51%
|
57.00
|
| Non Current Deferred Liabilities |
|
15,270.00
+626.45%
|
2,102.00
-11.98%
|
2,388.00
+44.12%
|
1,657.00
|
| Non Current Deferred Revenue |
|
1,162.00
-2.60%
|
1,193.00
-23.28%
|
1,555.00
-2.63%
|
1,597.00
|
| Non Current Deferred Taxes Liabilities |
|
14,108.00
+1452.04%
|
909.00
+9.12%
|
833.00
+1288.33%
|
60.00
|
| Other Non Current Liabilities |
|
2,141.00
-22.87%
|
2,776.00
+114.69%
|
1,293.00
+56.73%
|
825.00
|
| Stockholders Equity |
|
333,388.00
+18.83%
|
280,550.00
+21.45%
|
230,991.00
+21.24%
|
190,527.00
|
| Common Stock Equity |
|
333,388.00
+18.83%
|
280,550.00
+21.45%
|
230,991.00
+21.24%
|
190,527.00
|
| Capital Stock |
|
834.00
+0.00%
|
834.00
+0.12%
|
833.00
+0.12%
|
832.00
|
| Common Stock |
|
834.00
+0.00%
|
834.00
+0.12%
|
833.00
+0.12%
|
832.00
|
| Share Issued |
|
834.46
+0.04%
|
834.09
+0.17%
|
832.64
+0.06%
|
832.13
|
| Ordinary Shares Number |
|
832.00
-0.08%
|
832.64
+0.22%
|
830.78
+0.12%
|
829.79
|
| Treasury Shares Number |
|
2.45
+69.24%
|
1.45
-21.92%
|
1.86
-20.78%
|
2.34
|
| Additional Paid In Capital |
|
11,306.00
+3.36%
|
10,938.00
+6.81%
|
10,241.00
+4.96%
|
9,757.00
|
| Retained Earnings |
|
315,793.00
+19.05%
|
265,257.00
+23.04%
|
215,593.00
+22.70%
|
175,712.00
|
| Gains Losses Not Affecting Retained Earnings |
|
3,979.00
+509.34%
|
653.00
-26.30%
|
886.00
+17.35%
|
755.00
|
| Treasury Stock |
|
2,264.00
+128.46%
|
991.00
-21.91%
|
1,269.00
-20.74%
|
1,601.00
|
| Minority Interest |
|
3,778.00
|
0.00
|
—
|
—
|
| Other Equity Adjustments |
|
3,979.00
+509.34%
|
653.00
-26.30%
|
886.00
+17.35%
|
755.00
|
| Total Equity Gross Minority Interest |
|
337,166.00
+20.18%
|
280,550.00
+21.45%
|
230,991.00
+21.24%
|
190,527.00
|
| Total Capitalization |
|
337,188.00
+18.58%
|
284,350.00
+23.10%
|
230,991.00
+18.87%
|
194,327.00
|
| Working Capital |
|
119,720.00
-21.24%
|
152,010.00
+28.38%
|
118,408.00
+34.80%
|
87,841.00
|
| Invested Capital |
|
375,233.00
+26.31%
|
297,073.00
+22.67%
|
242,181.00
+9.38%
|
221,409.00
|
| Total Debt |
|
46,766.00
+133.60%
|
20,020.00
+48.60%
|
13,472.00
-60.20%
|
33,845.00
|
| Net Debt |
|
27,191.00
+188.77%
|
9,416.00
+74.02%
|
5,411.00
-66.24%
|
16,030.00
|
| Capital Lease Obligations |
|
4,921.00
+40.72%
|
3,497.00
+53.24%
|
2,282.00
-22.98%
|
2,963.00
|
| Net Tangible Assets |
|
224,775.00
-6.09%
|
239,346.00
+22.18%
|
195,897.00
+23.31%
|
158,863.00
|
| Tangible Book Value |
|
224,775.00
-6.09%
|
239,346.00
+22.18%
|
195,897.00
+23.31%
|
158,863.00
|
| Available For Sale Securities |
|
9,050.00
+3534.54%
|
249.00
-11.70%
|
282.00
-91.34%
|
3,256.00
|
| Current Provisions |
|
6,168.00
+14.58%
|
5,383.00
-1.30%
|
5,454.00
+28.09%
|
4,258.00
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
1,341.00
+65.56%
|
810.00
+114.29%
|
378.00
-8.25%
|
412.00
|
| Investmentin Financial Assets |
|
10,391.00
+881.21%
|
1,059.00
+60.45%
|
660.00
-82.01%
|
3,668.00
|
| Line Of Credit |
|
38,045.00
+199.03%
|
12,723.00
+72.17%
|
7,390.00
-72.71%
|
27,082.00
|
| Other Equity Interest |
|
3,740.00
-3.08%
|
3,859.00
-18.02%
|
4,707.00
-7.20%
|
5,072.00
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
46,428.00
+2.19%
|
45,433.00
-22.83%
|
58,875.00
+109.46%
|
28,108.00
|
| Cash Flow From Continuing Operating Activities |
|
46,428.00
+2.19%
|
45,433.00
-22.83%
|
58,875.00
+109.46%
|
28,108.00
|
| Net Income From Continuing Operations |
|
57,245.00
+2.80%
|
55,684.00
+23.56%
|
45,067.00
+91.22%
|
23,568.00
|
| Depreciation Amortization Depletion |
|
17,058.00
+14.94%
|
14,841.00
+17.45%
|
12,636.00
+6.87%
|
11,824.00
|
| Depreciation |
|
10,505.00
+9.70%
|
9,576.00
|
—
|
—
|
| Amortization Cash Flow |
|
6,553.00
+24.46%
|
5,265.00
|
—
|
—
|
| Depreciation And Amortization |
|
17,058.00
+14.94%
|
14,841.00
+17.45%
|
12,636.00
+6.87%
|
11,824.00
|
| Amortization Of Intangibles |
|
6,553.00
+24.46%
|
5,265.00
|
—
|
—
|
| Other Non Cash Items |
|
152.00
+126.81%
|
-567.00
-328.63%
|
248.00
+3642.86%
|
-7.00
|
| Stock Based Compensation |
|
424.00
+4.18%
|
407.00
+2.52%
|
397.00
-32.94%
|
592.00
|
| Provisionand Write Offof Assets |
|
161.00
-41.45%
|
275.00
+34.15%
|
205.00
+272.73%
|
55.00
|
| Asset Impairment Charge |
|
6,913.00
+93.86%
|
3,566.00
-35.96%
|
5,568.00
-54.16%
|
12,146.00
|
| Deferred Tax |
|
19,539.00
+20.72%
|
16,186.00
+5.79%
|
15,300.00
+75.26%
|
8,730.00
|
| Deferred Income Tax |
|
19,539.00
+20.72%
|
16,186.00
+5.79%
|
15,300.00
+75.26%
|
8,730.00
|
| Operating Gains Losses |
|
-1,528.00
+3.35%
|
-1,581.00
-43.60%
|
-1,101.00
+57.46%
|
-2,588.00
|
| Unrealized Gain Loss On Investment Securities |
|
-3,554.00
-12.86%
|
-3,149.00
-259.47%
|
-876.00
-216.25%
|
-277.00
|
| Net Foreign Currency Exchange Gain Loss |
|
211.00
+139.51%
|
-534.00
+43.13%
|
-939.00
-22.58%
|
-766.00
|
| Change In Working Capital |
|
-29,989.00
-48.59%
|
-20,182.00
-156.93%
|
-7,855.00
+57.54%
|
-18,498.00
|
| Change In Receivables |
|
-10,283.00
-27.68%
|
-8,054.00
-40.02%
|
-5,752.00
+66.19%
|
-17,012.00
|
| Change In Inventory |
|
-12,753.00
+30.86%
|
-18,445.00
-594.99%
|
-2,654.00
+73.22%
|
-9,912.00
|
| Change In Payables And Accrued Expense |
|
340.00
-90.17%
|
3,460.00
+14943.48%
|
23.00
-99.48%
|
4,412.00
|
| Change In Payable |
|
340.00
-90.17%
|
3,460.00
+14943.48%
|
23.00
-99.48%
|
4,412.00
|
| Change In Other Working Capital |
|
-7,293.00
-355.27%
|
2,857.00
+441.10%
|
528.00
-86.85%
|
4,014.00
|
| Investing Cash Flow |
|
-58,077.00
-44.17%
|
-40,283.00
+2.63%
|
-41,373.00
-56.79%
|
-26,387.00
|
| Cash Flow From Continuing Investing Activities |
|
-58,077.00
-44.17%
|
-40,283.00
+2.63%
|
-41,373.00
-56.79%
|
-26,387.00
|
| Net PPE Purchase And Sale |
|
-26,992.00
-75.97%
|
-15,339.00
-36.46%
|
-11,241.00
+21.34%
|
-14,290.00
|
| Purchase Of PPE |
|
-27,504.00
-67.68%
|
-16,403.00
-44.86%
|
-11,323.00
+22.76%
|
-14,660.00
|
| Sale Of PPE |
|
512.00
-51.88%
|
1,064.00
+1197.56%
|
82.00
-77.84%
|
370.00
|
| Capital Expenditure |
|
-34,398.00
-25.38%
|
-27,435.00
-45.42%
|
-18,866.00
+0.96%
|
-19,049.00
|
| Capital Expenditure Reported |
|
—
|
—
|
-18,866.00
+0.96%
|
-19,049.00
|
| Net Investment Purchase And Sale |
|
25,118.00
+259.95%
|
-15,704.00
+32.79%
|
-23,366.00
-108.61%
|
-11,201.00
|
| Purchase Of Investment |
|
-254,458.00
-74.90%
|
-145,488.00
-6.84%
|
-136,171.00
-53.05%
|
-88,972.00
|
| Sale Of Investment |
|
279,576.00
+115.42%
|
129,784.00
+15.05%
|
112,805.00
+45.05%
|
77,771.00
|
| Net Business Purchase And Sale |
|
-53,413.00
-445008.33%
|
-12.00
|
0.00
+100.00%
|
-326.00
|
| Purchase Of Business |
|
-53,413.00
-445008.33%
|
-12.00
|
0.00
+100.00%
|
-326.00
|
| Net Intangibles Purchase And Sale |
|
-6,162.00
+44.04%
|
-11,011.00
-45.98%
|
-7,543.00
-422.73%
|
-1,443.00
|
| Purchase Of Intangibles |
|
-6,894.00
+37.51%
|
-11,032.00
-46.25%
|
-7,543.00
-71.86%
|
-4,389.00
|
| Financing Cash Flow |
|
18,911.00
+602.55%
|
-3,763.00
+85.99%
|
-26,861.00
-1009.04%
|
-2,422.00
|
| Cash Flow From Continuing Financing Activities |
|
18,911.00
+602.55%
|
-3,763.00
+85.99%
|
-26,861.00
-1009.04%
|
-2,422.00
|
| Net Issuance Payments Of Debt |
|
23,196.00
+433.73%
|
4,346.00
+121.31%
|
-20,397.00
-845.78%
|
2,735.00
|
| Issuance Of Debt |
|
0.00
-100.00%
|
3,800.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-1,294.00
+73.84%
|
-4,947.00
-387.39%
|
-1,015.00
-29.30%
|
-785.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
3,800.00
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-1,294.00
+73.84%
|
-4,947.00
-387.39%
|
-1,015.00
-29.30%
|
-785.00
|
| Net Long Term Debt Issuance |
|
-1,294.00
-12.82%
|
-1,147.00
-13.00%
|
-1,015.00
-29.30%
|
-785.00
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
3,520.00
|
| Short Term Debt Payments |
|
—
|
—
|
-19,382.00
|
—
|
| Net Short Term Debt Issuance |
|
24,490.00
+345.84%
|
5,493.00
+128.34%
|
-19,382.00
-650.63%
|
3,520.00
|
| Net Common Stock Issuance |
|
-1,196.00
-248.57%
|
805.00
+118.75%
|
368.00
+10.18%
|
334.00
|
| Common Stock Payments |
|
-1,389.00
|
0.00
|
0.00
|
0.00
|
| Cash Dividends Paid |
|
-6,662.00
-0.21%
|
-6,648.00
-33.52%
|
-4,979.00
-20.09%
|
-4,146.00
|
| Repurchase Of Capital Stock |
|
-1,389.00
|
0.00
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
7,056.00
|
—
|
—
|
—
|
| Changes In Cash |
|
7,262.00
+423.58%
|
1,387.00
+114.82%
|
-9,359.00
-1235.09%
|
-701.00
|
| Effect Of Exchange Rate Changes |
|
224.00
+479.66%
|
-59.00
-120.63%
|
286.00
-60.98%
|
733.00
|
| Beginning Cash Position |
|
7,107.00
+22.98%
|
5,779.00
-61.09%
|
14,852.00
+0.22%
|
14,820.00
|
| End Cash Position |
|
14,593.00
+105.33%
|
7,107.00
+22.98%
|
5,779.00
-61.09%
|
14,852.00
|
| Free Cash Flow |
|
12,030.00
-33.16%
|
17,998.00
-55.02%
|
40,009.00
+341.65%
|
9,059.00
|
| Common Stock Issuance |
|
193.00
-76.02%
|
805.00
+118.75%
|
368.00
+10.18%
|
334.00
|
| Dividends Received CFI |
|
0.00
-100.00%
|
445.00
|
0.00
|
0.00
|
| Earnings Losses From Equity Investments |
|
-217.00
-47.62%
|
-147.00
+60.27%
|
-370.00
+47.37%
|
-703.00
|
| Interest Paid CFF |
|
-3,483.00
-53.71%
|
-2,266.00
-22.29%
|
-1,853.00
-37.77%
|
-1,345.00
|
| Interest Received CFI |
|
3,372.00
+152.02%
|
1,338.00
+72.20%
|
777.00
-11.00%
|
873.00
|
| Issuance Of Capital Stock |
|
193.00
-76.02%
|
805.00
+118.75%
|
368.00
+10.18%
|
334.00
|
| Sale Of Intangibles |
|
732.00
+3385.71%
|
21.00
|
0.00
-100.00%
|
2,946.00
|
| Taxes Refund Paid |
|
-19,993.00
+0.27%
|
-20,047.00
-87.11%
|
-10,714.00
-44.06%
|
-7,437.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42016-09-09 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|